London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of ...

EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...

Many of us think of chickenpox as a childhood illness, a harmless rite of passage that fades into memory once the itchy blisters heal. However, what most people don’t realize is that the virus behind ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Sheryl Lee Ralph exclusively told Us Weekly she is ready to reunite with Denzel Washington for an 'adult rom-com' ...

This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...

Now, six months into the NSW Pharmacy Dermatology Trial, pharmacists are now also appropriately trained to manage impetigo ...

Herpes zoster, commonly known as shingles, is caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. Recent research has explored the relationship between ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...